Table 1.
Clinical characteristics of children with infantile oxalosis
| Characteristic | Value |
|---|---|
| Number of patients, n | 95 |
| Male gender, n (%) | 59/95 (62) |
| Diagnosis | |
| Age at first symptoms, median (IQR) | 0.3 (0.2–0.4) |
| Age at diagnosis, median (IQR) | 0.4 (0.3–0.6) |
| Diagnosis through family screening, n (%) | 4/63 (6.3) |
Findings at diagnosis, n (%)
|
66/81 (82) 10/71 (14) 84/94 (89) |
| Age at ESKD, median (IQR) | 0.4 (0.3–0.5) |
| Follow-up | |
| Lost to follow-up, n (%) | 6 (6) |
| Follow-up time, median (IQR) | 3.6 (1.1–9.7) |
| Age at follow-up, median (IQR) | 4.2 (1.5–10) |
| Patients with systemic oxalosis, n (%) | 54/56 (96) |
| Patients with intensive dialysis, n (%) | 30/41 (71) |
| Transplanted patients (LKTx, LTx, or KTx), n (%) | 66/87 (76) |
| Age at first transplantation, median (IQR) | 1.7 (1.3–2.9) |
| Time between diagnosis and first transplantation, median (IQR) | 1.3 (0.9–2.1) |
| Deceased patients, n (%) | 27/89 (30) |
| Age at death, median (IQR) | 1.4 (0.6–2.0) |
ESKD, end-stage kidney disease; KTx, kidney transplantation; IQR, interquartile range; LKTx, liver-kidney transplantation; LTx, liver transplantation.
Values are either expressed as median with IQR or as n with percentage of (sub)group. Age or time is expressed in years.